TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 DKK)
| Closing information | 2025/09 | 2024/09 | 2023/09 |
| Turnover |
3,482
|
3,858
|
4,289 |
| Financial expenses |
18
|
0
|
0 |
| Earnings before taxes |
2,304
|
2,728
|
2,978 |
| EBITDA |
2,306
|
2,436
|
2,717 |
| Total assets |
17,872
|
16,749
|
14,428 |
| Current assets |
2,047
|
1,854
|
5,622 |
| Current liabilities |
832
|
1,654
|
1,857 |
| Equity capital |
16,534
|
14,729
|
12,357 |
| - share capital |
34
|
33
|
32 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Solvency |
92.5%
|
87.9%
|
85.6% |
| Turnover per employee |
1,741
|
1,929
|
2,144 |
| Profit as a percentage of turnover |
66.2%
|
70.7%
|
69.4% |
| Return on assets (ROA) |
13.0%
|
16.3%
|
20.6% |
| Current ratio |
246.0%
|
112.1%
|
302.7% |
| Return on equity (ROE) |
13.9%
|
18.5%
|
24.1% |
| Change turnover |
-466
|
-503
|
326 |
| Change turnover % |
-12%
|
-12%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.